Working with Industry
The Institute of Cancer Research, London, has an unrivalled track record at discovering new cancer drugs and medical technologies. We’re convinced that working in close partnership with industry is essential to take results into the clinic as soon as possible, and make sure our research delivers maximum benefit for cancer patients.
Current partner opportunities
Opportunity: A small molecule drug conjugate as a novel prodrug-activating platform
Commissioner: Professor Udai Banerji
Opportunity: antibody-derived small molecules and ‘macrodrug’ degraders
Commissioner: Professor Terence Rabbitts
Opportunity: A deep-learning method to improve the analysis of MRI in clinical imaging
Commissioner: Dr Matthew Blackledge
Opportunity: Novel method for sequencing the T-cell receptor from degraded RNA
Commissioner: Dr Annie Baker
Our Therapeutic Pipeline
Through industry partnerships, our cancer drug discovery programmes have led to 21 candidates since 2005 - of which 13 have entered clinical trials.
Our Business and Innovation Office
The ICR's Business and Innovation Office is made up of a skilled team of staff with many decades’ experience in collaborating and contracting with commercial organisations.Our work with industry
Find out more about our work with industry - including collaboration, licensing and consultancy opportunities.